Skip main navigation
Close Drawer MenuOpen Drawer Menu

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Back to table of contents
Letter to the EditorFull Access

Addition of Naltrexone to Fluoxetine in the Treatment of Binge Eating Disorder

Published Online:1 May 1999https://doi.org/10.1176/ajp.156.5.797

References

  • 1. Fluoxetine Bulimia Nervosa Collaborative Study Group: Fluoxetine in the treatment of bulimia nervosa. Arch Gen Psychiatry 1992; 49:139–147 Crossref, Medline, Google Scholar
  • 2. deZwaan M, Mitchell JE: Opiate antagonists and eating behavior in humans: a review. J Clin Pharmacol 1992; 32:1060–1072 Google Scholar
  • 3. Simeon JG, Dinicola VF, Ferguson HB, Copping W: Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Prog Neuropsychopharmacol Biol Psychiatry 1990; 14:791–795 Crossref, Medline, Google Scholar